158 related articles for article (PubMed ID: 21931376)
21. Role of surveillance in prevention of hepatocellular carcinoma.
Panda D
J Clin Exp Hepatol; 2014 Aug; 4(Suppl 3):S43-9. PubMed ID: 25755610
[TBL] [Abstract][Full Text] [Related]
22. Serum biomarker signature is predictive of the risk of hepatocellular cancer in patients with cirrhosis.
El-Serag H; Kanwal F; Ning J; Powell H; Khaderi S; Singal AG; Asrani S; Marrero JA; Amos CI; Thrift AP; Luster M; Alsarraj A; Olivares L; Skapura D; Deng J; Salem E; Najjar O; Yu X; Duong H; Scheurer ME; Ballantyne CM; Kaochar S
Gut; 2024 Feb; ():. PubMed ID: 38365278
[TBL] [Abstract][Full Text] [Related]
23. Discovering Novel Prognostic Biomarkers of Hepatocellular Carcinoma using eXplainable Artificial Intelligence.
Gutierrez-Chakraborty E; Chakraborty D; Das D; Bai Y
bioRxiv; 2023 Nov; ():. PubMed ID: 38076789
[TBL] [Abstract][Full Text] [Related]
24. Novel biomarkers and strategies for HCC diagnosis and care.
Wang AE; Leven EA; Grinspan LT; Villanueva A
Clin Liver Dis (Hoboken); 2024; 23(1):e0152. PubMed ID: 38707238
[No Abstract] [Full Text] [Related]
25. EASL Clinical Practice Guidelines: Management of hepatocellular carcinoma.
;
J Hepatol; 2018 Jul; 69(1):182-236. PubMed ID: 29628281
[No Abstract] [Full Text] [Related]
26. Diagnostic Evaluation of Des-Gamma-Carboxy Prothrombin versus α-Fetoprotein for Hepatitis B Virus-Related Hepatocellular Carcinoma in China: A Large-Scale, Multicentre Study.
Ji J; Wang H; Li Y; Zheng L; Yin Y; Zou Z; Zhou F; Zhou W; Shen F; Gao C
PLoS One; 2016; 11(4):e0153227. PubMed ID: 27070780
[TBL] [Abstract][Full Text] [Related]
27. Alpha-fetoprotein-L3 in hepatocellular carcinoma: a meta-analysis.
Yi X; Yu S; Bao Y
Clin Chim Acta; 2013 Oct; 425():212-20. PubMed ID: 23954771
[TBL] [Abstract][Full Text] [Related]
28. The threshold of alpha-fetoprotein (AFP) for the diagnosis of hepatocellular carcinoma: A systematic review and meta-analysis.
Zhang J; Chen G; Zhang P; Zhang J; Li X; Gan D; Cao X; Han M; Du H; Ye Y
PLoS One; 2020; 15(2):e0228857. PubMed ID: 32053643
[TBL] [Abstract][Full Text] [Related]
29. GALAD Score Detects Early Hepatocellular Carcinoma in an International Cohort of Patients With Nonalcoholic Steatohepatitis.
Best J; Bechmann LP; Sowa JP; Sydor S; Dechêne A; Pflanz K; Bedreli S; Schotten C; Geier A; Berg T; Fischer J; Vogel A; Bantel H; Weinmann A; Schattenberg JM; Huber Y; Wege H; von Felden J; Schulze K; Bettinger D; Thimme R; Sinner F; Schütte K; Weiss KH; Toyoda H; Yasuda S; Kumada T; Berhane S; Wichert M; Heider D; Gerken G; Johnson P; Canbay A
Clin Gastroenterol Hepatol; 2020 Mar; 18(3):728-735.e4. PubMed ID: 31712073
[TBL] [Abstract][Full Text] [Related]
30. A Novel Online Calculator Based on Serum Biomarkers to Detect Hepatocellular Carcinoma among Patients with Hepatitis B.
Yang T; Xing H; Wang G; Wang N; Liu M; Yan C; Li H; Wei L; Li S; Fan Z; Shi M; Chen W; Cai S; Pawlik TM; Soh A; Beshiri A; Lau WY; Wu M; Zheng Y; Shen F
Clin Chem; 2019 Dec; 65(12):1543-1553. PubMed ID: 31672853
[TBL] [Abstract][Full Text] [Related]
31. Surveillance for Hepatocellular Carcinoma: Current Best Practice and Future Direction.
Kanwal F; Singal AG
Gastroenterology; 2019 Jul; 157(1):54-64. PubMed ID: 30986389
[TBL] [Abstract][Full Text] [Related]
32. Longitudinal Assessment of Three Serum Biomarkers to Detect Very Early-Stage Hepatocellular Carcinoma.
Choi J; Kim GA; Han S; Lee W; Chun S; Lim YS
Hepatology; 2019 May; 69(5):1983-1994. PubMed ID: 30153338
[TBL] [Abstract][Full Text] [Related]
33. The prognostic correlation of AFP level at diagnosis with pathological grade, progression, and survival of patients with hepatocellular carcinoma.
Bai DS; Zhang C; Chen P; Jin SJ; Jiang GQ
Sci Rep; 2017 Oct; 7(1):12870. PubMed ID: 28993684
[TBL] [Abstract][Full Text] [Related]
34. The Burden of Primary Liver Cancer and Underlying Etiologies From 1990 to 2015 at the Global, Regional, and National Level: Results From the Global Burden of Disease Study 2015.
; Akinyemiju T; Abera S; Ahmed M; Alam N; Alemayohu MA; Allen C; Al-Raddadi R; Alvis-Guzman N; Amoako Y; Artaman A; Ayele TA; Barac A; Bensenor I; Berhane A; Bhutta Z; Castillo-Rivas J; Chitheer A; Choi JY; Cowie B; Dandona L; Dandona R; Dey S; Dicker D; Phuc H; Ekwueme DU; Zaki MS; Fischer F; Fürst T; Hancock J; Hay SI; Hotez P; Jee SH; Kasaeian A; Khader Y; Khang YH; Kumar A; Kutz M; Larson H; Lopez A; Lunevicius R; Malekzadeh R; McAlinden C; Meier T; Mendoza W; Mokdad A; Moradi-Lakeh M; Nagel G; Nguyen Q; Nguyen G; Ogbo F; Patton G; Pereira DM; Pourmalek F; Qorbani M; Radfar A; Roshandel G; Salomon JA; Sanabria J; Sartorius B; Satpathy M; Sawhney M; Sepanlou S; Shackelford K; Shore H; Sun J; Mengistu DT; Topór-Mądry R; Tran B; Ukwaja KN; Vlassov V; Vollset SE; Vos T; Wakayo T; Weiderpass E; Werdecker A; Yonemoto N; Younis M; Yu C; Zaidi Z; Zhu L; Murray CJL; Naghavi M; Fitzmaurice C
JAMA Oncol; 2017 Dec; 3(12):1683-1691. PubMed ID: 28983565
[TBL] [Abstract][Full Text] [Related]
35. Asia-Pacific clinical practice guidelines on the management of hepatocellular carcinoma: a 2017 update.
Omata M; Cheng AL; Kokudo N; Kudo M; Lee JM; Jia J; Tateishi R; Han KH; Chawla YK; Shiina S; Jafri W; Payawal DA; Ohki T; Ogasawara S; Chen PJ; Lesmana CRA; Lesmana LA; Gani RA; Obi S; Dokmeci AK; Sarin SK
Hepatol Int; 2017 Jul; 11(4):317-370. PubMed ID: 28620797
[TBL] [Abstract][Full Text] [Related]
36. The GALAD scoring algorithm based on AFP, AFP-L3, and DCP significantly improves detection of BCLC early stage hepatocellular carcinoma.
Best J; Bilgi H; Heider D; Schotten C; Manka P; Bedreli S; Gorray M; Ertle J; van Grunsven LA; Dechêne A
Z Gastroenterol; 2016 Dec; 54(12):1296-1305. PubMed ID: 27936479
[No Abstract] [Full Text] [Related]
37. Hepatocellular carcinoma: Review of disease and tumor biomarkers.
Kim JU; Shariff MI; Crossey MM; Gomez-Romero M; Holmes E; Cox IJ; Fye HK; Njie R; Taylor-Robinson SD
World J Hepatol; 2016 Apr; 8(10):471-84. PubMed ID: 27057305
[TBL] [Abstract][Full Text] [Related]
38. Hepatocellular carcinoma tumour markers: current role and expectations.
Rich N; Singal AG
Best Pract Res Clin Gastroenterol; 2014 Oct; 28(5):843-53. PubMed ID: 25260312
[TBL] [Abstract][Full Text] [Related]
39. The detection of hepatocellular carcinoma using a prospectively developed and validated model based on serological biomarkers.
Johnson PJ; Pirrie SJ; Cox TF; Berhane S; Teng M; Palmer D; Morse J; Hull D; Patman G; Kagebayashi C; Hussain S; Graham J; Reeves H; Satomura S
Cancer Epidemiol Biomarkers Prev; 2014 Jan; 23(1):144-53. PubMed ID: 24220911
[TBL] [Abstract][Full Text] [Related]
40. Performance of PIVKA-II for early hepatocellular carcinoma diagnosis and prediction of microvascular invasion.
Poté N; Cauchy F; Albuquerque M; Voitot H; Belghiti J; Castera L; Puy H; Bedossa P; Paradis V
J Hepatol; 2015 Apr; 62(4):848-54. PubMed ID: 25450201
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
